Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR
Clinical trial NCT02416388 · RECRUITING
Trial details
- NCT number
- NCT02416388
- Sponsor
- University Hospital, Angers
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2025-07-30
- Enrollment
- 3100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.